shortagewatch

Home / Cancer and immune system / Cyclophosphamide

ATC L01AA01 · Antineoplastic Agents

Cyclophosphamide shortage

As of 31 Oct 2026, Cyclophosphamide has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 18 products.

Countries5/5
Products18packs or presentations
Short since23 Dec 202510 months ago
Earliest return31 Dec 2026company estimate
No return date4products
Main reasonManufacturing problem
Germany8 packs shortItaly3 packs shortSpain2 packs shortAustria3 packs shortBelgium2 packs short

Timeline

GermanyItalySpainAustriaBelgium
202620272028Endoxan 1 gEndoxan 1 gEndoxan 1 gEndoxan 1 gEndoxan 1 gEndoxan 1 gEndoxan 200 mgEndoxan 200 mgEndoxan 200 mgEndoxan 200 mgEndoxan 500 mgEndoxan 500 mgEndoxan 500 mgEndoxan 500 mgEndoxan 500 mgEndoxan 500 mgENDOXAN BAXTERENDOXAN BAXTERENDOXAN BAXTERENDOXAN BAXTERENDOXAN BAXTERENDOXAN BAXTERCICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vialCICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRCICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 1 mlEndoxan "Baxter" 1 g - Trockenstechampulle, Endoxan "Baxter" 1 g - Trockenstechampulle, 10 StückEndoxan "Baxter" 200 mg - TrockenstechampullEndoxan "Baxter" 200 mg - Trockenstechampulle, 10 StückEndoxan "Baxter" 500 mg - TrockenstechampullEndoxan "Baxter" 500 mg - Trockenstechampulle, 1 StückEndoxan 1 g inj./inf. sol. (pwdr.) i.m./i.v.Endoxan 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 1000 mgEndoxan 500 mg inj./inf. sol. (pwdr.) i.m./iEndoxan 500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial 5 x 500 mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEEndoxan 1 gBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 1 gBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 1 gBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 200 mgBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 200 mgBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 500 mgBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 500 mgBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEEndoxan 500 mgBaxter Deutschland GmbH21 Jan 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
ITENDOXAN BAXTERBAXTER S.P.A.23 Dec 2025not givenIncreased demand
Elevata richiesta/problemi produttivi: distribuzione contingentata
ITENDOXAN BAXTERBAXTER S.P.A.23 Dec 2025not givenIncreased demand
Elevata richiesta/problemi produttivi: distribuzione contingentata
ITENDOXAN BAXTERBAXTER S.P.A.17 Aug 2026not givenManufacturing problem
Problemi produttivi
ESCICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vialSeacross Pharma (Europe) Limited1 Feb 2026not givenNot stated
ESCICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 1 mlReddy Pharma Iberia S.A.9 Feb 20263 Jan 2028Not stated
ATEndoxan "Baxter" 1 g - Trockenstechampulle, 10 Stück limitedBaxter Healthcare GmbH25 Feb 202631 Mar 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung
ATEndoxan "Baxter" 200 mg - Trockenstechampulle, 10 Stück limitedBaxter Healthcare GmbH25 Feb 202631 Mar 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung
ATEndoxan "Baxter" 500 mg - Trockenstechampulle, 1 Stück limitedBaxter Healthcare GmbH25 Feb 202631 Mar 2027Manufacturing problem
Kapazitätsengpässe bei der Herstellung
BEEndoxan 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 1000 mg limitedBaxter22 Jun 202631 Dec 2026Manufacturing problem
Delay in production
BEEndoxan 500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial 5 x 500 mg limitedBaxter22 Jun 202631 Dec 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Bendamustine Ifosfamide Melphalan Trofosfamide